Vasculopathy is rarely reported in neurofibromatosis type 1, but when it occurs it primarily involves the aorta and its main branches. Among vasculopathies, aneurysmal dilatation is the most common form. Although several case reports concerning aneurysms or pseudoaneurysms of visceral arteries in neurofibromatosis type 1 patients have been reported, there are no reports describing gastroduodenal artery aneurysms associated with neurofibromatosis type 1. We experienced a case of life-threatening duodenal ulcer bleeding from a ruptured gastroduodenal artery aneurysm associated with neurofibromatosis type 1. We treated our patient by transarterial embolization after initial endoscopic hemostasis. To our knowledge, this is the first reported case of its type. High levels of suspicion and prompt diagnosis are required to select appropriate treatment options for patients with neurofibromatosis type 1 experiencing upper gastrointestinal bleeding. Embolization of the involved arteries should be considered an essential treatment over endoscopic hemostasis alone to achieve complete hemostasis and to prevent rebleeding. (Korean J Gastroenterol 2015;66:164-167) 
INTRODUCTION
Neurofibromatosis type 1 is an autosomal dominant disorder of variable penetration affecting 1 in 3,000 people that predominantly involves abnormal growth of neuroectodermal tumors in the peripheral nervous system. Other clinical manifestations include café-au-lait spots, Lisch nodules of the iris, meningeal tumors and skin fold freckling. 1, 2 Besides these features, vasculopathy sometimes occurs with neurofibromatosis. The pathogenesis of neurofibromatosis vasculopathy is not completely understood but may be associated with dysfunction of the neurofibromin in vascular smooth muscle and endothelial cells. [3] [4] [5] Neurofibromatosis type 1 is caused by mutations of NF1 gene, which encodes neurofibromin. 6 Aneurysm formation in neurofibromatosis type 1 may be attributable to friable vascular structure secondary to arterial dysplasia or vascular invasion by neurofibroma.
Vascular lesions occur in 3.6% of patients with neuro- Fig. 1 . Photograph of the patient shows a number of cutaneous neurofibromas on the neck and trunk. (Fig. 3) . After selectively probing the gastroduodenal artery and aneurysm with a microcatheter, embolization was performed at the distal and proximal segments from the aneurysm using two coils (diameter 6 mm, length 14 cm, Nester Ⓡ Embolization Microcoil; Cook Medical, Bloomington, IN, USA) (Fig. 4) . These consecutive procedures produced immediate cessation of radio-contrast extravasation and there were no immediate complications. Upper endoscopy five days after TAE revealed the active duodenal ulcer with the metallic coil at the ulcer base (Fig. 5A) , and 11 days after TAE a follow-up endoscopic view showed the ulcer with regenerating epithelium, and the coil material was not visible (Fig. 5B ). There were no stigmata of recent bleeding observed on these sequential endoscopic examinations. During first follow-up endoscopy, gastric mu- 15 found that 35% of gastroduodenal artery aneurysms are already ruptured at presentation, with an associated mortality rate of 21%. The most common clinical event associated with ruptured gastroduodenal artery aneurysms is UGIB, which occurs in 50% of patients, with retroperitoneal and intraperitoneal bleeding occurring less frequently. 15 To the best of our knowledge, this is the first case of duodenal ulcer bleeding resulting from a ruptured gastroduodenal artery aneurysm in a patient with neurofibromatosis type 1.
This case suggests that a high level of suspicion for aneurysmal rupture bleeding is needed to select appropriate treatment options for such patients, and that embolization of the involved arteries should be considered an essential treatment over endoscopic hemostasis alone to prevent recurrent bleeding in such cases.
